Brand-name · GLP-1 receptor agonist (semaglutide)

Ozempic®

A once-weekly semaglutide injection FDA-approved for type 2 diabetes. Prescribed off-label for weight management in select patients when clinically appropriate.

Starting at$349.99/mo

Check If I Qualify Read the FAQs

Form

Pre-filled injection pen

Frequency

Once weekly

Drug class

GLP-1 receptor agonist (semaglutide)

Who is a candidate for this medication?

Adults 18+ with type 2 diabetes needing improved glycemic control.
Off-label use for weight requires physician judgement.

Who this medication is not for

Personal or family history of medullary thyroid cancer or MEN 2.
Pregnancy, planning pregnancy, or breastfeeding.
Type 1 diabetes.

Dosage overview

Phase	Dose
Weeks 1–4	0.25 mg once weekly.
Titration	Increased every 4 weeks to 0.5, 1.0, or 2.0 mg based on response.

Side effects to know about

Common

· Nausea
· Diarrhea
· Vomiting
· Abdominal pain

Serious (call your doctor)

· Pancreatitis
· Retinopathy complications
· Kidney injury

How your care is monitored

A1c and weight review each visit.
Hypoglycemia risk assessment when combined with insulin or sulfonylureas.

Pricing

Ozempic® starts at $349.99/mo. No insurance required. HSA/FSA eligible. Cancel anytime.

Common questions

Can I get Ozempic just for weight loss?

Physicians typically prefer FDA-approved weight-loss options (Wegovy, Zepbound, compounded semaglutide/tirzepatide). Ozempic may be considered off-label case by case.